Butabarbital decreases results of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of CYP3A4 inducers may well lower sufentanil stages and efficacy, perhaps precipitating withdrawal syndrome in clients who may have created physical dependence to sufentanil. Discontinuation of concomitantly utilized CYP3A4 inducers... https://annu234igd3.blog-mall.com/profile